// App-Quantinova.ai

: L-Carnitine Does Not Reduce Cytotoxicity from Induction Chemotherapy for Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Jessica Sea

Principal Investigators

  • Etan Orgel

  • Steven D. Mittelman

Medical Centers

  • Division of Endocrinology, UCLA, Los Angeles, CA

  • Hematology, Oncology, Blood and Marrow Transplantation,Children's Hospital Los Angeles,Los Angeles,United States

  • University of Southern California, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • sodium pyruvate

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Daunorubicin

  • Levocarnitine

  • Vincristine

  • Carnitine

  • Glutamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved